Gene · 1495
Papers2,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| What should be the future direction of development in the field of prostate cancer with lung metastasis? | World J Clin Oncol | 2023 | 37970109 | PubTator, text mining | PubMed |
| Latin American young patients with gastric adenocarcinoma: worst prognosis and outcomes. | J Gastrointest Oncol | 2023 | 37969836 | PubTator, text mining | PubMed |
| Cadherin dysregulation in gastric cancer: insights into gene expression, pathways, and prognosis. | J Gastrointest Oncol | 2023 | 37969819 | PubTator, text mining | PubMed |
| A hidden gem Catenin-α-1 is essential for Chikungunya virus infection. | Microbiol Spectr | 2023 | 37962368 | PubTator, text mining | PubMed |
| Identification of hub gene and lncRNA signature related to entotic cell death in cutaneous melanoma for prognostic and immune prediction. | Medicine (Baltimore) | 2023 | 37960805 | PubTator, text mining | PubMed |
| Mechanisms Underlying Rare Inherited Pediatric Retinal Vascular Diseases: FEVR, Norrie Disease, Persistent Fetal Vascular Syndrome. | Cells | 2023 | 37947657 | PubTator, text mining | PubMed |
| lncRNA HOXC-AS2 promotes the progression of hypopharyngeal cancer by binding to the P62 protein mediating the autophagy process. | Aging (Albany NY) | 2023 | 37944249 | PubTator, text mining | PubMed |
| LY6/PLAUR domain containing 3 (LYPD3) maintains melanoma cell stemness and mediates an immunosuppressive microenvironment. | Biol Direct | 2023 | 37924160 | PubTator, text mining | PubMed |
| MTSS1 is downregulated in nasopharyngeal carcinoma (NPC) which disrupts adherens junctions leading to enhanced cell migration and invasion. | Front Cell Dev Biol | 2023 | 37920825 | PubTator, text mining | PubMed |
| Uncovering key molecular mechanisms in the early and late-stage of papillary thyroid carcinoma using association rule mining algorithm. | PLoS One | 2023 | 37917782 | PubTator, text mining | PubMed |
| Unlocking the Potential of the CA2, CA7, and ITM2C Gene Signatures for the Early Detection of Colorectal Cancer: A Comprehensive Analysis of RNA-Seq Data by Utilizing Machine Learning Algorithms. | Genes (Basel) | 2023 | 37895185 | PubTator, text mining | PubMed |
| Intracranial Aneurysms and Genetics: An Extensive Overview of Genomic Variations, Underlying Molecular Dynamics, Inflammatory Indicators, and Forward-Looking Insights. | Brain Sci | 2023 | 37891822 | PubTator, text mining | PubMed |
| Assessment of Inner Blood-Retinal Barrier: Animal Models and Methods. | Cells | 2023 | 37887287 | PubTator, text mining | PubMed |
| Sleeping Beauty transposon mutagenesis identified genes and pathways involved in inflammation-associated colon tumor development. | Nat Commun | 2023 | 37845228 | PubTator, text mining | PubMed |
| ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer. | Database (Oxford) | 2023 | 37815872 | PubTator, text mining | PubMed |
| Gastric Cancer: A Practical Review on Management of Individuals with Hereditary or Familial Risk for Gastric Cancer. | GE Port J Gastroenterol | 2023 | 37767311 | PubTator, text mining | PubMed |
| HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. | Curr Issues Mol Biol | 2023 | 37754227 | PubTator, text mining | PubMed |
| Integrated proteomics and phosphoproteomics analyses of esophageal cancer cells with different invasive abilities. | Life Sci | 2023 | 37734435 | PubTator, text mining | PubMed |
| A 96-wells fluidic system for high-throughput screenings under laminar high wall shear stress conditions. | Microsyst Nanoeng | 2023 | 37719414 | PubTator, text mining | PubMed |
| Preclinical Evidence for the Use of Oral Mesenchymal Stem Cell-Derived Extracellular Vesicles in Bone Regenerative Therapy: A Systematic Review. | Stem Cells Transl Med | 2023 | 37715961 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1495/papers?page=6